Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells - Wikidata - wikimedia - TriplyDB

Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells

Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells

http://www.wikidata.org/entity/Q35827006

about

Phage therapy of pulmonary infections Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections Phage cocktails and the future of phage therapy Phage therapy against Enterococcus faecalis in dental root canals Modular Approach to Select Bacteriophages Targeting Pseudomonas aeruginosa for Their Application to Children Suffering With Cystic Fibrosis Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections.A mathematical model to guide antibiotic treatment strategies.The susceptibility of Pseudomonas aeruginosa strains from cystic fibrosis patients to bacteriophages.Pseudomonas aeruginosa adaptation to lungs of cystic fibrosis patients leads to lowered resistance to phage and protist enemies UFV-P2 as a member of the Luz24likevirus genus: a new overview on comparative functional genome analyses of the LUZ24-like phages Scaffold-based anti-infection strategies in bone repair.Investigation of a Large Collection of Pseudomonas aeruginosa Bacteriophages Collected from a Single Environmental Source in Abidjan, Côte d'Ivoire.In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients.Isolation of a Novel Phage with Activity against Streptococcus mutans Biofilms.Pseudomonas biofilms, cystic fibrosis, and phage: a silver lining?A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections.Phage fitness may help predict phage therapy efficacy.Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms.Complete genome sequence of the bacteriophage YMC01/01/P52 PAE BP, which causes lysis of verona integron-encoded metallo-β-lactamase-producing, carbapenem-resistant Pseudomonas aeruginosa.Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung.Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications.Genomic and proteomic analyses of the terminally redundant genome of the Pseudomonas aeruginosa phage PaP1: establishment of genus PaP1-like phages Morphology, physiological characteristics, and complete sequence of marine bacteriophage ϕRIO-1 infecting Pseudoalteromonas marina.Monoclonal antibodies against DNA-binding tips of DNABII proteins disrupt biofilms in vitro and induce bacterial clearance in vivo.Back to the future: evolving bacteriophages to increase their effectiveness against the pathogen Pseudomonas aeruginosa PAO1 Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections.Complete Genome Sequences of Pseudomonas aeruginosa Phages vB_PaeP_PcyII-10_P3P1 and vB_PaeM_PcyII-10_PII10A.Quorum sensing controls the Pseudomonas aeruginosa CRISPR-Cas adaptive immune system.A Novel Antimicrobial Endolysin, LysPA26, against Pseudomonas aeruginosa Molecular dissection of phage endolysin: an interdomain interaction confers host specificity in Lysin A of Mycobacterium phage D29.Biofilm infections, their resilience to therapy and innovative treatment strategies.Novel avenues for Clostridium difficile infection drug discovery.A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.Use of bacteriophages in the treatment of Pseudomonas aeruginosa infections.Phage therapy: eco-physiological pharmacology.Strategies for combating bacterial biofilm infections.Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.Genome Sequence of Pseudomonas aeruginosa Strain DK1-NH57388A, a Stable Mucoid Cystic Fibrosis Isolate.

P2860

Q26781119-6A6910C3-409A-4D8B-8E0B-C11F97B17312 Q26786947-94314920-797A-4FF3-9971-BA2EF12B02F8 Q26799417-CC7DE809-F34E-417A-B767-FB1B93ADE495 Q26823401-52EA5C2B-3936-453F-AE68-EBB615FA322E Q26995797-6431C0C4-EA13-4570-9FF7-CA958FB4C8A2 Q28071930-2736FA2F-FE60-44D8-8DD4-82E97B148FF2 Q28076246-1AA0B7A4-E98F-4677-9F9C-084CF260776F Q33798541-64BA190F-396C-4EAF-9DF6-A4734BE942AF Q34378364-CB573528-77F0-4C32-B226-DEFF9599D756 Q34699939-F1A41C7E-A5EB-4D86-8FC6-313020E912E9 Q34999578-9103EE25-DF64-47F3-ACB3-10DA445A26F0 Q35079610-106DF139-5EBC-4BF0-AC0E-922A391B18F3 Q35235414-93BE7FF7-172C-4BF7-B06F-69F1F18C3AE5 Q35675668-8AEB3ABD-0F3D-4C6A-90A7-8E874416F285 Q35780029-AAB64733-4EBF-4EC6-BF4A-84FB8BB12904 Q35785449-7D423BEB-BEDD-43B2-B8FD-1D0742447A7F Q35878716-4D700128-6D3D-4B42-A688-C1EA92619E43 Q36052205-66065F44-3421-4293-AB93-8C07489FE30A Q36110277-0A9387C7-51EB-4DC9-A76E-1B9E0ACD6360 Q36246210-4631F642-06E3-45E0-81B4-8648774DE5F4 Q36414475-AF3649D1-8C7C-46E8-99CE-4D39683FF5E7 Q36571855-EF8E3F35-4619-487F-9E71-26924D6355DE Q36676044-E1D6AFAF-D3F6-4D0C-968D-F7B03573F386 Q36840401-312B5F5B-C16A-4640-B85C-428DAC5CDD5E Q37123363-D1F9B3B9-5F23-48EA-8F44-3EEC69C738BA Q37221382-405DCD02-0C6F-4138-97D3-0CF5D714D0CE Q37244657-A17C74C0-F95C-4AF3-9DCF-155BC0F24468 Q37335751-EF0D7A96-A0BD-49CD-86CE-0F76FB08A9D8 Q37421356-0192CE7E-A0A1-4695-AC30-2EC7B9D02113 Q37577200-730E79CA-1BC9-417C-B2A5-4BCEFB0157E1 Q37667229-21CEB549-6772-4865-A259-D738968FA514 Q37727646-E0381872-FC19-4A6B-AD80-2E4A6B8C4F7E Q38048367-D8E4B175-0DD3-4F9A-A4F7-5913615A3AE5 Q38083297-03267A65-A571-4B2B-AE05-556C8F9051C7 Q38131268-35142BDF-C979-4096-94C8-A1B715C6AD4F Q38140012-9F15EEB7-457B-4B6C-8F65-122D8C08DE2D Q38230407-80B57215-733F-49E5-8837-FA3668294BAB Q38287542-C2887396-B333-40F2-99F9-529FDF1E56BF Q38599969-EF5D27A5-2A75-4A3D-8B3D-C7FF638D3E5F Q38636624-A89FFF0A-5D4A-42D9-A7F1-B83A66065AB6

P2860

Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells

http://www.wikidata.org/entity/Q35827006

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Bacteriophages φMR299-2 and φN ...... tic fibrosis lung airway cells

@ast

Bacteriophages φMR299-2 and φN ...... tic fibrosis lung airway cells

@en

type

label

Bacteriophages φMR299-2 and φN ...... tic fibrosis lung airway cells

@ast

Bacteriophages φMR299-2 and φN ...... tic fibrosis lung airway cells

@en

prefLabel

Bacteriophages φMR299-2 and φN ...... tic fibrosis lung airway cells

@ast

Bacteriophages φMR299-2 and φN ...... tic fibrosis lung airway cells

@en

P1433

Q35827006-1127B59B-0761-4D56-9F1C-A613FD4D4841

P1476

Q35827006-AB47BF9C-FD1C-4D49-8F40-BC8089E7DCC0

P2093

Q35827006-0128E20A-5819-4A4F-8362-FE28C96C007E

Q35827006-25C5BE7E-5273-4446-9F92-C83339772AE4

Q35827006-6A608860-DEDC-4352-A76C-EC83DDD2B7E5

Q35827006-8AECAC34-D9AA-44E4-8E4F-BA2C2A106EEF

Q35827006-8B91995A-4B7A-4E92-8FE5-72E62EE294E0

Q35827006-9A40B815-100D-449C-8192-4E9D39B13328

Q35827006-B301BA43-5E01-4C96-A900-7BCA2AD1ADE6

Q35827006-E0E71B4F-7F57-4303-9E3F-C8E83C472741

Q35827006-FB2C4879-F30F-4F2D-AE70-5771B278C016

P2860

Q35827006-0561294D-6FE3-4A1A-8F80-2D6DC2799CD6

Q35827006-0C5D58EC-7D7B-434B-A31E-6025BC5A6196

Q35827006-0F3FBF6E-2AEE-4FB3-864F-5F0C39334F5F

Q35827006-1C77D11A-20D6-4B99-AD96-09CEC07D155D

Q35827006-2025BF52-4E36-4992-AEC3-51D04C679478

Q35827006-229AAF4B-E4D9-4CB1-B714-BE9A2258AE84

Q35827006-2A67DDDC-45DC-4C12-BFFD-4DF87FAC59FD

Q35827006-2E5DCC3F-7472-4D2B-9E4D-C61ABF31421D

Q35827006-32F63ED8-2086-4361-B3CC-4980976B7DDA

Q35827006-3A8250D0-1FBE-492F-8FD6-1C23E6B3D86F

P304

Q35827006-6F768CC2-B82D-40C9-9788-74829C7AE255

P31

Q35827006-502E7B5E-5FC4-4272-A385-4BF27BE9CAE5

P356

Q35827006-F5CD0E58-EA03-4E78-952D-BB3C55F9E748

P433

Q35827006-D4CAE2F7-85D1-4D0B-BBED-205D175454C1

P478

Q35827006-3078F6B1-FDFB-48D5-8A6E-7F2F36EA9ABF

P50

Q35827006-84BDE2C2-D50A-4D90-AB35-7A88D2DFEC31

P577

Q35827006-8850C4BF-C102-4302-8D03-DF0B82A79CE7

P5875

Q35827006-FFAD0462-1416-4618-BA07-69F7B92F90AE

P698

Q35827006-2C988BAC-CBB2-4795-A6A7-F34DCAC3474F

P921

Q35827006-89871B6D-7A50-467F-9E91-A88727912E66

Q35827006-A08F5EE9-05F5-4B9E-84F1-2DE593B0AB2C

Q35827006-D6516734-1546-44D4-9425-195572CC12DA

P932

Q35827006-CB93BA9B-C761-46B4-8234-0AD012745BBD

P356

P1433

P1476

Bacteriophages φMR299-2 and φN ...... tic fibrosis lung airway cells

@en

P2093

Aidan Coffey

http://www.w3.org/2001/XMLSchema#string

Caitriona M Guinane

http://www.w3.org/2001/XMLSchema#string

Colin Hill

http://www.w3.org/2001/XMLSchema#string

Debebe Alemayehu

http://www.w3.org/2001/XMLSchema#string

Fergus Shanahan

http://www.w3.org/2001/XMLSchema#string

James G Martin

http://www.w3.org/2001/XMLSchema#string

Olivia McAuliffe

http://www.w3.org/2001/XMLSchema#string

Pat G Casey

http://www.w3.org/2001/XMLSchema#string

R Paul Ross

http://www.w3.org/2001/XMLSchema#string

P2860

The RAST Server: rapid annotations using subsystems technology

Identification of the cystic fibrosis gene: chromosome walking and jumping

Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

Genome Annotation Transfer Utility (GATU): rapid annotation of viral genomes using a closely related reference genome

Basic local alignment search tool

Improved microbial gene identification with GLIMMER

Base-calling of automated sequencer traces using phred. II. Error probabilities

Bacterial biofilms: a common cause of persistent infections

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

P304

e00029-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/MBIO.00029-12

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221683262

http://www.w3.org/2001/XMLSchema#string

P698

22396480

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

Pseudomonas aeruginosa

P932

3302570

http://www.w3.org/2001/XMLSchema#string